Search the Newsroom
Filter By
Showing 2011 - 2020 of 2926 results
Make the Diagnosis: Spring 2019
An 18-month-old girl returns for a follow-up appointment with her urologist. She has a history of VUR and a duplex kidney. What imaging study will help guide her further care?
Children’s Doctor News and Updates: Spring 2019
Latest news include our Department of Pediatrics ranking, new research study findings, a new book by Dr. Zur, new videos and more.
PCU Nurses Discuss Recruiting and Retaining Millennials
Young nurses are looking to join “the best of the best” and grow in their careers.
Researchers Use Gene Editing with CRISPR to Treat Lethal Lung Diseases before Birth
CHOP/Penn Medicine animal study published in Science Translational Medicine shows promise for developing new therapies for treating lethal lung diseases.
The Cardiac Center at CHOP Celebrates Major Milestone with Big Hearts to Little Hearts
Clinical leaders at the Cardiac Center at CHOP celebrated a major milestone with Big Hearts to Little Hearts, a nonprofit organization dedicated to raising funds for congenital heart disease research.
The Health Benefits of Gardening
Check out the many benefits of gardening and how the Gardens at CHOP provide unique and vital resources to our patients and their families.
Q&A with a CHOP Resident: Sheyla Richards, MD, MS
For Sheyla Richards, MD, MS, a first-year pediatrics resident, the diversity of the faculty at CHOP creates a sense of belonging and support as she goes through her training.
Expanding Therapeutic Hypothermia Services to Improve Care for Neonates with Neurological Conditions
Level III NICUs throughout the CHOP Newborn Care Network are moving to start their own therapeutic hypothermia programs through a coordinated effort.
A Severe CLD Patient, a Complicated Success Story
This case study illustrates how infants with severe chronic lung disease can make great improvements with multidisciplinary, individualized care.
Gene-based Clotting Factor Prevents Bleeding in Animals with Hemophilia
A laboratory study may set the stage for a new preventive treatment for hemophilia patients who now develop antibodies to the standard treatment and then require a bypass therapy.